Weekly epidemiological record 2 October 2020 No 40, 2019, 484-487 Progress in eliminating onchocerciasis in the WHO Region of the Americas: advances towards transmission
This is footage[1] of microfilariae was captured in a 59-year-old man’s anterior chamber of the eye. The man lives in an onchocerciasis-endemic area in
Parasites Vectors 13, 258 (2020). Published May 15, 2020. Authors: Jérémy T Campillo, Cédric B Chesnais, Sébastien D Pion, Jacques Gardon, Joseph Kamgno, Michel
Progress report on the elimination of human onchocerciasis, 2018–2019. Weekly Epidemiological Record. WHO, 2019. Overview November 8, 2019 Onchocerciasis is a parasitic infection caused
Weekly epidemiological record 13 September 2019 No. 94 (37): 415 – 419 Progress in eliminating onchocerciasis in the WHO Region of the Americas: doxycycline
Progress report on the elimination of human onchocerciasis, 2017–2018. Weekly Epidemiological Record. WHO, 2018 Overview Onchocerciasis, commonly known as “river blindness”, is a parasitic
Weekly epidemiological record 12 October 2018 No. 93 (41): 541 – 544 Progress towards eliminating onchocerciasis in the WHO Region of the Americas: advances
On June 14, 2018, the US FDA approved moxidectin as a treatment for onchocerciasis (river blindness). We applaud Medicines Development for Global Health (MDGH)
Article on the importance of cross-border issues in onchocerciasis elimination programmes. Bush, Sodahlon, Downs and Mackenzie, International Health, Volume 10, Issue suppl_1, 1 March 2018,
Article on the use of alternative (or complementary) treatment strategies (ATSs) to accelerate the elimination of onchocerciasis. Boussinesq et al., International Health, Volume 10,
Article on eliminating onchocercias as a public health problem in Uganda. Katabarwa et al, International Health, Volume 10, Issue suppl_1, 1 March 2018, Pages
A review summarizing the progress made in identifying diagnostics that meet the specialized requirements needed to verify onchocerciasis elimination, as well as a discussion
Article on the acquisition of quality-assured (QA) data that ultimately define the absence of infection or transmission of onchocerciasis in previously endemic areas in Africa. International
This publication reviews the history of the efforts to control onchocerciasis in Yemen and the current status of the disease, and identifies the essential
Journal article discussing the concept that all areas where the worm that causes onchocerciasis might currently be transmitted—and where mass drug administration (MDA) with
Joni Lawrence, Yao K Sodahlon International Health, Volume 10, Issue suppl_1, March 2018, Pages i1–i2, https://doi.org/10.1093/inthealth/ihx070 The purpose of this publication is to provide proof of
